AU2001256977A1 - Human sez6 nucleic acids and polypeptides - Google Patents
Human sez6 nucleic acids and polypeptidesInfo
- Publication number
- AU2001256977A1 AU2001256977A1 AU2001256977A AU5697701A AU2001256977A1 AU 2001256977 A1 AU2001256977 A1 AU 2001256977A1 AU 2001256977 A AU2001256977 A AU 2001256977A AU 5697701 A AU5697701 A AU 5697701A AU 2001256977 A1 AU2001256977 A1 AU 2001256977A1
- Authority
- AU
- Australia
- Prior art keywords
- polypeptides
- nucleic acids
- human sez6
- sez6
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20020000P | 2000-04-28 | 2000-04-28 | |
US60200200 | 2000-04-28 | ||
PCT/US2001/010809 WO2001083552A2 (en) | 2000-04-28 | 2001-04-17 | Human sez6 nucleic acids and polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001256977A1 true AU2001256977A1 (en) | 2001-11-12 |
Family
ID=22740721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001256977A Abandoned AU2001256977A1 (en) | 2000-04-28 | 2001-04-17 | Human sez6 nucleic acids and polypeptides |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1290026A2 (en) |
AU (1) | AU2001256977A1 (en) |
WO (1) | WO2001083552A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6401060B2 (en) | 2012-02-24 | 2018-10-03 | アッヴィ・ステムセントルクス・エル・エル・シー | Anti-SEZ6 antibody and method of use |
EP3338793A1 (en) | 2013-08-28 | 2018-06-27 | AbbVie Stemcentrx LLC | Novel sez6 modulators and methods of use |
EP3892294A1 (en) * | 2013-08-28 | 2021-10-13 | AbbVie Stemcentrx LLC | Site-specific antibody conjugation methods and compositions |
JP2017514143A (en) | 2014-02-21 | 2017-06-01 | アッヴィ・ステムセントルクス・エル・エル・シー | Anti-DLL3 antibodies and drug conjugates for use in melanoma |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001010902A2 (en) * | 1999-08-11 | 2001-02-15 | Curagen Corporation | Nucleoc acids and secreted polypeptides encoded thereby |
WO2001025268A1 (en) * | 1999-10-04 | 2001-04-12 | Schrotz King Petra | Human seizure related proteins |
-
2001
- 2001-04-17 WO PCT/US2001/010809 patent/WO2001083552A2/en not_active Application Discontinuation
- 2001-04-17 EP EP01930440A patent/EP1290026A2/en not_active Withdrawn
- 2001-04-17 AU AU2001256977A patent/AU2001256977A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001083552A3 (en) | 2002-05-16 |
WO2001083552A2 (en) | 2001-11-08 |
EP1290026A2 (en) | 2003-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001249251A1 (en) | Novel nucleic acids and polypeptides | |
AU2001243142A1 (en) | Novel nucleic acids and polypeptides | |
AU2001234944A1 (en) | Novel nucleic acids and polypeptides | |
AU2001290548A1 (en) | Novel nucleic acids and polypeptides | |
AU2001245280A1 (en) | Novel nucleic acids and polypeptides | |
AU2001233041A1 (en) | Novel nucleic acids and polypeptides | |
AU2001238347A1 (en) | Novel nucleic acids and polypeptides | |
AU2001296235A1 (en) | Novel nucleic acids and polypeptides | |
AU2002246502A1 (en) | Nucleic acids and polypeptides | |
AU2001263006A1 (en) | Novel nucleic acids and polypeptides | |
AU2001233017A1 (en) | Novel nucleic acids and polypeptides | |
AU2001241511A1 (en) | Novel nucleic acids and polypeptides | |
AU2001292561A1 (en) | Nucleic acids and polypeptides | |
AU2002246808A1 (en) | Human nucleic acids and polypeptides and methods of use thereof | |
AU2001250872A1 (en) | Novel nucleic acids and polypeptides | |
WO2002016439A8 (en) | Novel nucleic acids and polypeptides | |
EP1341803A4 (en) | Novel nucleic acids and polypeptides | |
AU2001239889A1 (en) | Polypeptides and nucleic acids encoding same | |
AU2001262934A1 (en) | Human fgf-20 nucleic acids and polypeptides | |
AU3511100A (en) | Novel nucleic acids and polypeptides | |
AU2001264955A1 (en) | Human cyslt2 nucleic acids, polypeptides, and uses thereof | |
AU2001256977A1 (en) | Human sez6 nucleic acids and polypeptides | |
AU2001266813A1 (en) | Human proteins and nucleic acids encoding same | |
AU2002250419A1 (en) | Novel nucleic acids and polypeptides | |
AU2001263005A1 (en) | Novel nucleic acids and polypeptides |